These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 18311490)
1. Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas. Belaud-Rotureau MA; Marietta V; Vergier B; Mainhaguiet G; Turmo M; Idrissi Y; Ferrer J; Beylot-Barry M; Dubus P; Merlio JP Virchows Arch; 2008 Jun; 452(6):607-20. PubMed ID: 18311490 [TBL] [Abstract][Full Text] [Related]
2. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas. Kaune KM; Neumann C; Hallermann C; Haller F; Schön MP; Middel P Exp Dermatol; 2011 Apr; 20(4):331-5. PubMed ID: 21410763 [TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID. Dijkman R; Tensen CP; Buettner M; Niedobitek G; Willemze R; Vermeer MH Blood; 2006 Jun; 107(12):4926-9. PubMed ID: 16507780 [TBL] [Abstract][Full Text] [Related]
12. [Cutaneous B-cell lymphoma. Classification and diagnostics]. Geissinger E; Adam P; Müller-Hermelink HK; Rüdiger T Pathologe; 2007 Feb; 28(1):15-20. PubMed ID: 17195038 [TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity. Paulli M; Viglio A; Vivenza D; Capello D; Rossi D; Riboni R; Lucioni M; Incardona P; Boveri E; Bellosta M; Orlandi E; Borroni G; Lazzarino M; Berti E; Alessi E; Magrini U; Gaidano G Hum Pathol; 2002 Sep; 33(9):937-43. PubMed ID: 12378521 [TBL] [Abstract][Full Text] [Related]
14. Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma. van Galen JC; Hoefnagel JJ; Vermeer MH; Willemze R; Dijkman R; Tensen CP; de Boer WP; Meijer CJ; Oudejans JJ J Pathol; 2008 Jul; 215(3):340-6. PubMed ID: 18498125 [TBL] [Abstract][Full Text] [Related]
15. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910 [TBL] [Abstract][Full Text] [Related]
16. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea. Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248 [TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions. Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985 [TBL] [Abstract][Full Text] [Related]
18. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas. Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621 [TBL] [Abstract][Full Text] [Related]
19. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835 [TBL] [Abstract][Full Text] [Related]
20. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related. Geelen FA; Vermeer MH; Meijer CJ; Van der Putte SC; Kerkhof E; Kluin PM; Willemze R J Clin Oncol; 1998 Jun; 16(6):2080-5. PubMed ID: 9626207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]